Related Experiment Videos
The sham ECT literature: implications for consent to ECT.
1Colin A. Ross Institute for Psychological Trauma, 1701 Gateway, Suite 349, Richardson, TX 75080, USA.
Ethical Human Psychology and Psychiatry
|July 22, 2006
Summary
Electroconvulsive therapy (ECT) shows no significant difference compared to sham ECT in treating depression, according to a review of placebo-controlled studies. Further research is needed to confirm its efficacy and inform patient consent.
Area of Science:
- Neuroscience
- Psychiatry
- Clinical Trials
Background:
- Electroconvulsive therapy (ECT) is a widely used treatment for severe depression.
- The efficacy of ECT compared to placebo remains a subject of debate and investigation.
Purpose of the Study:
- To critically evaluate the placebo-controlled literature on electroconvulsive therapy (ECT) for depression.
- To assess the consistency of published data with claims regarding ECT's effectiveness.
Main Methods:
- Systematic review of placebo-controlled studies investigating electroconvulsive therapy (ECT) for depression.
- Analysis of study outcomes at 1 month posttreatment and during the treatment period.
Main Results:
- No placebo-controlled study demonstrated a significant difference between real and sham ECT at 1 month posttreatment.
- Many studies failed to show a significant difference between real and sham ECT even during active treatment.
Conclusions:
- Published data do not consistently support claims of ECT's effectiveness for depression.
- A large, well-designed study comparing real versus sham ECT is warranted.
- Current consent forms for ECT should reflect the lack of controlled evidence for benefit at 1 month and the marginal difference over placebo.